Oxford Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Oxford Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-459,550	Closed	-$9.39M	–	2066
2018 Q4	$9.39M	Hold	459,550	–	–	0.24%	80
2018 Q3	$9.28M	Hold	459,550	–	–	0.19%	106
2018 Q2	$9.15M	Hold	459,550	–	–	0.18%	116
2018 Q1	$9.09M	Buy	459,550 +10,000	+2%	+$196K	0.19%	86
2017 Q4	$8.75M	Buy	449,550 +440,900	+5,097%	+$8.59M	0.19%	98
2017 Q3	$169K	Buy	+8,650	New	+$168K	﹤0.01%	1441

Other funds holding DMTK

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Oxford Asset Management's DMTK Position: Q1 2019 in Review

Oxford Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2019, closing a stake of 459,550 shares — an estimated $9.39M sold.

Oxford Asset Management first reported a position in DMTK in Q3 2017 and held it in 6 quarters. The position peaked at $9.39M in Q4 2018. 5 funds tracked by Wall St. Rank hold DMTK as of Q1 2019.

Oxford Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Oxford Asset Management sold 459,550 DermTech, Inc. Common Stock shares in Q1 2019, an estimated $9.39M.
Oxford Asset Management first reported a position in DermTech, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
Oxford Asset Management's DermTech, Inc. Common Stock position peaked at $9.39M in Q4 2018.
5 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2019.

Based on Oxford Asset Management's 13F filing for Q1 2019, filed 15 May 2019.